A Study of a Dietary Supplement on Serum Biomarkers in Children
Part of paid clinical trials in San Francisco, California.
- Sponsor
- SF Research Institute, Inc.
- Study ID
- NCT07385144
- Status
- Recruiting
Conditions
- Nutritional Status
- Serum Biomarkers
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Years - 15 Years
- Healthy Volunteers
- Accepted
Interventions
- Dietary Supplement (Kids Multi & Omegas) — DIETARY_SUPPLEMENTThe intervention consists of a gummy dietary supplement administered orally to healthy children. Participants will be instructed to take two gummies once daily, with or without food, starting on Day 1 and continuing for a total duration of 4 weeks. The supplement contains vitamins, minerals, and omega-3 fatty acids, including vitamin D, vitamin B12, folate, and polyunsaturated fatty acids (DHA and EPA). The intervention is evaluated by measuring serum nutritional biomarkers at baseline and after 4 weeks of supplementation.
Study Details
This is a pilot clinical study designed to evaluate the effects of a dietary supplement on selected blood-based nutritional biomarkers in healthy children aged 4 to 15 years. Approximately 24 children will be screened and enrolled to account for potential dropouts, with a target of 20 participants completing the study. Eligible participants will attend a screening and baseline visit, followed by daily intake of the study supplement for 4 weeks. After the supplementation period, participants will return to the clinic for an end-of-study visit. Blood samples will be collected at baseline and after 4 weeks to measure nutritional biomarkers, including vitamin D, vitamin B12, folate, omega-3 fatty acids, and standard blood count parameters. Additional assessments include height, weight, body mass index (BMI), and a socioeconomic questionnaire. Throughout the study, participants or their caregivers will record daily supplement intake, any medications taken, and any adverse events in a study diary. The results of this pilot study will provide preliminary data on the effects of the dietary supplement on serum biomarkers in children.
Key Dates
- Start date
- Jan 30, 2026
- Status verified
- Feb 2026
- Primary completion
- Feb 28, 2026
- Completion
- Mar 5, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Dietary Supplement GroupParticipants in this arm will receive the investigational dietary supplement (Kids Multi \& Omegas) in gummy form. Subjects will be instructed to take two gummies once daily, with or without food, for a total duration of 4 weeks. Blood samples will be collected at baseline and at the end of the study to evaluate changes in selected serum nutritional biomarkers.
Primary Outcome Measure
Change in Serum 25-Hydroxyvitamin D From Baseline to Week 4 [ Time Frame: Baseline (Day 1) and End of Study (Week 4) ]
Central Contacts
- Dr. John Ademola415-845-4638
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| San Francisco Research Institute | San Francisco | California | 94132 |